KWKuan-Lin Wu

Kuan-Lin Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kuan-Lin Wu has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Protein target highlights in CASP15: Analysis of models by structure providers

    by Leila T. Alexander, Janani Durairaj, Andriy Kryshtafovych, Luciano A. Abriata, Yusupha Bayo, Gira Bhabha, Cécile Breyton, Simon G. Caulton, James Chen, Séraphine Degroux, et al.

    We present an in‐depth analysis of selected CASP15 targets, focusing on their biological and functional significance. The authors of the structures identify and discuss key protein features and evaluate how effectively these aspects were captured in the submitted predictions. While the overall ability to predict three‐dimensional protein structures continues to impress, reproducing uncommon features not previously observed in experimental structures is still a challenge. Furthermore, instances with conformational flexibility and large multimeric complexes highlight the need for novel scoring strategies to better emphasize biologically relevant structural regions. Looking ahead, closer integration of computational and experimental techniques will play a key role in determining the next challenges to be unraveled in the field of structural molecular biology.


  • Expanding the eukaryotic genetic code with a biosynthesized 21st amino acid

    by Kuan‐Lin Wu, Joshua A. Moore, Mitchell D. Miller, Yuda Chen, Catherine Lee, Weijun Xu, Zane Peng, Qinghui Duan, George N. Phillips, Rosa A. Uribe, et al.

    Genetic code expansion technology allows for the use of noncanonical amino acids (ncAAs) to create semisynthetic organisms for both biochemical and biomedical applications. However, exogenous feeding of chemically synthesized ncAAs at high concentrations is required to compensate for the inefficient cellular uptake and incorporation of these components into proteins, especially in the case of eukaryotic cells and multicellular organisms. To generate organisms capable of autonomously biosynthesizing an ncAA and incorporating it into proteins, we have engineered a metabolic pathway for the synthesis of O‐methyltyrosine (OMeY). Specifically, we endowed organisms with a marformycins biosynthetic pathway‐derived methyltransferase that efficiently converts tyrosine to OMeY in the presence of the co‐factor S‐adenosylmethionine. The resulting cells can produce and site‐specifically incorporate OMeY into proteins at much higher levels than cells exogenously fed OMeY. To understand the structural basis for the substrate selectivity of the transferase, we solved the X‐ray crystal structures of the ligand‐free and tyrosine‐bound enzymes. Most importantly, we have extended this OMeY biosynthetic system to both mammalian cells and the zebrafish model to enhance the utility of genetic code expansion. The creation of autonomous eukaryotes using a 21st amino acid will make genetic code expansion technology more applicable to multicellular organisms, providing valuable vertebrate models for biological and biomedical research.


  • Open Access

    Harnessing the power of antibodies to fight bone metastasis

    by Zeru Tian, Ling Wu, Chenfei Yu, Yuda Chen, Zhan Xu, Igor Bado, Axel Loredo, Lushun Wang, Hai Wang, Kuan-Lin Wu, et al.

    Precision modification of antibodies with bone-targeting moieties unleashes their potential for the treatment of bone metastases.